CereGate

CereGate is a Brain-Machine Interface startup based in Germany that was founded in 2019. The company's slogan, "The Map is not the Territory," reflects its innovative approach to communication. CereGate aims to revolutionize the way humans interact with technology, particularly focusing on developing new methods to interface with the human brain. Their primary goal is to empower patients with neurological disorders or sensory deficits, providing them with the means to adapt and improve their conditions independently. One of the noteworthy achievements of CereGate is securing a Series A investment on 12 January 2022. The investment was led by prominent firms such as Heal Capital, TruVenturo, re.Mind Capital, 468 Capital, and HTGF | High-Tech Gruenderfonds. This latest financial backing not only signifies a vote of confidence from esteemed investors but also provides CereGate with the necessary resources to further develop their cutting-edge technologies. As a Medical Devices company, CereGate is uniquely positioned to make a substantial impact on the healthcare industry. Their dedication to enhancing patient independence and improving quality of life sets a strong foundation for future growth and success. With the recent investment, CereGate is well-positioned to continue their groundbreaking work in the field of brain-machine interface technology, offering promising prospects for both investors and the future of healthcare.